ET
RXST icon

Entropy Technologies’s RxSight RXST Stock Holding History

Entropy Technologies’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,355
Closed -$503K – 912
2024
Q2 		$503K Sell
8,355
-5,082
-38% -$290K 0.05% 396
2024
Q1 		$693K Buy
13,437
+5,399
+67% +$265K 0.07% 368
2023
Q4 		$324K Buy
+8,038
New +$236K 0.06% 431

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Entropy Technologies's RXST Position: Q3 2024 in Review

Entropy Technologies sold out of RxSight (RXST) in Q3 2024, closing a stake of 8,355 shares — an estimated $503K sold.

Entropy Technologies first reported a position in RXST in Q4 2023 and held it in 3 quarters. The position peaked at $693K in Q1 2024. 214 funds tracked by Wall St. Rank hold RXST as of Q3 2024.

  • Entropy Technologies reported no remaining RxSight position as of Q3 2024 after selling out during the quarter.
  • Entropy Technologies sold 8,355 RxSight shares in Q3 2024, an estimated $503K.
  • Entropy Technologies first reported a position in RxSight in Q4 2023 and held it in 3 quarters.
  • Entropy Technologies's RxSight position peaked at $693K in Q1 2024.
  • 214 funds tracked by Wall St. Rank held RxSight as of Q3 2024.

Based on Entropy Technologies's 13F filing for Q3 2024, filed 4 Nov 2024.